Literature DB >> 8642692

Nonspecific alcoholysis, a novel endonuclease activity of human immunodeficiency virus type 1 and other retroviral integrases.

M Katzman1, M Sudol.   

Abstract

Retroviral integrase (IN) exhibits a previously unrecognized endonuclease activity which we have termed nonspecific alcoholysis. This action occurred at every position in nonviral DNA sequences except those near 5' ends and is clearly distinguished from, and was not predicted by, the site-specific alcoholysis activity previously described for IN at the processing site near viral DNA termini. The integrases of human immunodeficiency virus type 1, visna virus, and Rous sarcoma virus exhibited different target site preferences in this new assay. The isolated central domain of human immunodeficiency virus type 1 IN preferred the same sites as the full-length protein. Nonspecific alcoholysis may provide insights into the structure and function of IN and other endonucleases and suggests that stimulators of some activities possessed by retroviral enzymes should be sought as antiviral agents.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642692      PMCID: PMC190108     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

Review 1.  Genetics of retroviral integration.

Authors:  S P Goff
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

2.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

3.  Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 4.  Molecular mechanism of retroviral DNA integration.

Authors:  J Kulkosky; A M Skalka
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

5.  Protection of retroviral DNA from autointegration: involvement of a cellular factor.

Authors:  M S Lee; R Craigie
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

6.  Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.

Authors:  A D Leavitt; R B Rose; H E Varmus
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

7.  Activities of the feline immunodeficiency virus integrase protein produced in Escherichia coli.

Authors:  C Vink; K H van der Linden; R H Plasterk
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Molecular recognition mediated by bound water. A mechanism for star activity of the restriction endonuclease EcoRI.

Authors:  C R Robinson; S G Sligar
Journal:  J Mol Biol       Date:  1993-11-20       Impact factor: 5.469

9.  Retroviral DNA integration: structure of an integration intermediate.

Authors:  T Fujiwara; K Mizuuchi
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

10.  Efficient magnesium-dependent human immunodeficiency virus type 1 integrase activity.

Authors:  A Engelman; R Craigie
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

View more
  15 in total

1.  An amino acid in the central catalytic domain of three retroviral integrases that affects target site selection in nonviral DNA.

Authors:  Amy L Harper; Malgorzata Sudol; Michael Katzman
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  The terminal nucleotide of the Mu genome controls catalysis of DNA strand transfer.

Authors:  Ilana Goldhaber-Gordon; Michael H Early; Tania A Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-09       Impact factor: 11.205

3.  Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.

Authors:  D Esposito; R Craigie
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

4.  Influence of subterminal viral DNA nucleotides on differential susceptibility to cleavage by human immunodeficiency virus type 1 and visna virus integrases.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Evaluation of a system to screen for stimulators of non-specific DNA nicking by HIV-1 integrase: application to a library of 50,000 compounds.

Authors:  Malgorzata Sudol; Jennifer L Fritz; Melissa Tran; Gavin P Robertson; Julie B Ealy; Michael Katzman
Journal:  Antivir Chem Chemother       Date:  2011-10-07

6.  A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.

Authors:  Wesley M Konsavage; Stephen Burkholder; Malgorzata Sudol; Amy L Harper; Michael Katzman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

7.  Use of patient-derived human immunodeficiency virus type 1 integrases to identify a protein residue that affects target site selection.

Authors:  A L Harper; L M Skinner; M Sudol; M Katzman
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Mapping viral DNA specificity to the central region of integrase by using functional human immunodeficiency virus type 1/visna virus chimeric proteins.

Authors:  M Katzman; M Sudol
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  Alternative nucleophilic substrates for the endonuclease activities of human immunodeficiency virus type 1 integrase.

Authors:  Julie B Ealy; Malgorzata Sudol; Jacek Krzeminski; Shantu Amin; Michael Katzman
Journal:  Virology       Date:  2012-08-19       Impact factor: 3.616

10.  Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.

Authors:  C Calmels; V Richard de Soultrait; A Caumont; C Desjobert; A Faure; M Fournier; L Tarrago-Litvak; V Parissi
Journal:  Nucleic Acids Res       Date:  2004-03-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.